Becton Dickinson (BDX) Retained Earnings (2009 - 2026)
Becton Dickinson's (BDX) quarterly Retained Earnings came in at $17.5 billion in Q2 2026, up 6.59% year-over-year from $16.4 billion in Q2 2025, and up 0.68% quarter-over-quarter from $17.4 billion in Q1 2026.
Analysis
Becton Dickinson (BDX) Retained Earnings (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Retained Earnings for 18 consecutive years, with $17.5 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Retained Earnings rose 6.59% year-over-year to $17.5 billion in Q2 2026; TTM through Jun 2026 was $17.5 billion, a 6.59% increase from a year earlier, with the FY2025 full-year figure at $16.6 billion, up 2.99% from the prior year.
- Retained Earnings was $17.5 billion for Q2 2026 at Becton Dickinson, up from $17.4 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $17.5 billion in Q2 2026 and troughed at -$1.9 billion in Q1 2022.
- A 5-year average of $7.5 billion and a median of $7.3 billion in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slipped 4.03% in 2023 and soared 1165.41% in 2024, its largest moves.
- Over 5 years, Retained Earnings stood at -$1.6 billion in 2022, then gained by 2.82% to -$1.5 billion in 2023, then soared by 1165.41% to $16.1 billion in 2024, then increased by 3.49% to $16.7 billion in 2025, then grew by 4.82% to $17.5 billion in 2026.
- The last three Retained Earnings figures came in at $17.5 billion (Q2 2026), $17.4 billion (Q1 2026), and $16.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 50.32 Bn | 49.46 Bn | 2.32 Bn | 17.51 Bn |
| 2 | Medline | 48.11 Bn | 52.93 Bn | 2.22 Bn | 11.40 Bn |
| 3 | West Pharmaceutical Services | 23.93 Bn | 23.49 Bn | 329.20 Mn | 4.62 Bn |
| 4 | Baxter International | 13.34 Bn | 11.16 Bn | 1.03 Bn | 13.81 Bn |
| 5 | Stevanato Group S.p.A | 6.21 Bn | 6.11 Bn | 100.91 Mn | 1.72 Bn |
| 6 | Acme United | 241.34 Mn | 236.30 Mn | 26.69 Mn | 107.10 Mn |
| 7 | Rockwell Medical | 31.74 Mn | 6.94 Mn | 3.24 Mn | 440.72 Mn |
| 8 | Retractable Technologies | 21.26 Mn | -18.61 Mn | 190,852.00 | 12.36 Mn |
| 9 | United Health Products | 12.24 Mn | 12.21 Mn | - | -82.08 Mn |
| 10 | Cuprina Holdings (Cayman) | 8.09 Mn | 4.97 Mn | - | -9.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.51 Bn |
| Mar 31, 2026 | 17.39 Bn |
| Dec 31, 2025 | 16.70 Bn |
| Sep 30, 2025 | 16.62 Bn |
| Jun 30, 2025 | 16.43 Bn |
| Mar 31, 2025 | 16.15 Bn |
| Dec 31, 2024 | 16.14 Bn |
| Sep 30, 2024 | 16.14 Bn |
| Jun 30, 2024 | 16.02 Bn |
| Mar 31, 2024 | -1.54 Bn |
| Dec 31, 2023 | -1.52 Bn |
| Sep 30, 2023 | -1.55 Bn |
| Jun 30, 2023 | -1.51 Bn |
| Mar 31, 2023 | -1.58 Bn |
| Dec 31, 2022 | -1.56 Bn |
| Sep 30, 2022 | -1.49 Bn |
| Jun 30, 2022 | -1.66 Bn |
| Mar 31, 2022 | -1.91 Bn |
| Dec 31, 2021 | -2.04 Bn |
| Sep 30, 2021 | -2.09 Bn |